The initial wave of antibody production after challenge with T-dependent antigen is produced by plasma cells generated from the rapid extrafollicular proliferative focus response (1) . Antigenspecifi c B cells are initially expanded through collaboration with CD4 + T helper cells at the interface between the T and B zones (2) (3) (4) . After 3-4 d, activated B cells can migrate to the bridging channels and red pulp of the spleen and form extrafollicular foci. Here they diff erentiate into plasma cells, many of which are short lived (5) and secrete antibodies that may be either switched (e.g., IgG1) or unswitched (IgM; references 1, 6) . B cells do not undergo somatic hypermutation (SHM) before or during the extrafollicular response; the resultant antibodies being comprised almost exclusively of specifi cities encoded within the primary repertoire (5, 7) . A second wave of T-dependent plasma cell production is subsequently derived from responding B cells that, instead of colonizing extrafollicular foci, enter the primary follicle and propogate within the germinal center (GC) reaction. In GCs, responding B cells collaborate with follicular T helper and dendritic cells to undergo SHM (8) with mutant clones that recognize the immunogen with increased affi nity being selectively propagated (affi nity maturation; reference 9). Plasma cells that contribute to the later post-GC phase of antibody production therefore typically express somatically mutated Ig genes (10) .
The decision between extrafollicular plasma cell diff erentiation and GC migration represents the fi rst major branch point during a T-dependent B cell response. Nevertheless, the physiological cues responsible for directing B cells down one pathway versus the other are currently unknown (1) . One theory is that responding cells B cells responding to T-dependent antigen either differentiate rapidly into extrafollicular plasma cells or enter germinal centers and undergo somatic hypermutation and affi nity maturation. However, the physiological cues that direct B cell differentiation down one pathway versus the other are unknown. Here we show that the strength of the initial interaction between B cell receptor (BCR) and antigen is a primary determinant of this decision. B cells expressing a defi ned BCR specifi city for hen egg lysozyme (HEL) were challenged with sheep red blood cell conjugates of a series of recombinant mutant HEL proteins engineered to bind this BCR over a 10,000-fold affi nity range. Decreasing either initial BCR affi nity or antigen density was found to selectively remove the extrafollicular plasma cell response but leave the germinal center response intact. Moreover, analysis of competing B cells revealed that high affi nity specifi cities are more prevalent in the extrafollicular plasma cell versus the germinal center B cell response. Thus, the effectiveness of early T-dependent antibody responses is optimized by preferentially steering B cells reactive against either high affi nity or abundant epitopes toward extrafollicular plasma cell differentiation. Conversely, responding clones with weaker antigen reactivity are primarily directed to germinal centers where they undergo affi nity maturation.
stochastically follow either response pathway such that the original specifi cities recruited into the response are represented equally in both the extrafollicular and early GC populations (11, 12) . Alternatively, diff erential recognition of antigen by B cell receptors (BCRs) expressed on individual B cells may infl uence their subsequent responses, in which case the specifi cities represented in the extrafollicular and early GC populations would diff er. Evidence for the stochastic model has come from analysis of responses to the hapten (4-hydroxy-3-nitrophenyl)acetyl (NP), where both low and high affi nity clones have been detected at similar frequencies in extrafollicular foci and early GCs (11) . However, the stochastic model is diffi cult to reconcile with data from other systems, indicating that relatively high affi nity specifi cities can dominate the initial T-dependent antibody response (13) (14) (15) . The question of whether the nature of the interaction between antigen and BCR infl uences cell fate during early T-dependent responses is therefore still controversial.
The two major variables that impact on the interaction of an antigen with a BCR are the affi nity of the epitope for the receptor's monovalent Fab and the density or valency of the epitope on the antigen. Manipulation of either of these variables can produce profound changes in the responses of B cells to BCR stimulation in vitro (16) (17) (18) (19) as well as to T-independent responses (20, 21) and induction of self-tolerance (22) (23) (24) in vivo. The uncertainty surrounding the impact of antigen affi nity and density on early T-dependent B cell responses is due largely to the diffi culty of tracking responding B cells in vivo and defi ning the precise nature of their initial interaction with the antigen.
To overcome these problems, we have developed gene-targeted mice expressing H and L chains of HyHEL10 anti-hen egg lysozyme (HEL) mAb (SW HEL ), in which B cells express a defi ned anti-HEL BCR and are capable of normal Ig class switching and SHM (6, 25) . By challenging CD45-allotyped marked SW HEL B cells with HEL coupled to sheep red blood cells (SRBC) in an adoptive transfer system, T-dependent responses can be accurately tracked in vivo by both immunohistology and fl ow cytometry (6) . In this study, SW HEL B cells were challenged with a range of recombinant HEL proteins engineered to recognize the SW HEL BCR over a 10,000-fold affi nity range and coupled to SRBC at diff erent antigen densities. Examination of the early T-dependent responses generated by the SW HEL B cells indicated that decreasing either antigen affi nity or density profoundly reduced the extrafollicular plasma cell response but had minimal impact on the GC reaction. Thus, although the requirements for GC entry are not stringent, responding B cells require a strong initial interaction with the antigen to contribute signifi cantly to the early plasma cell response. These results reveal that the initial antigen-BCR interaction plays a fundamental role in organizing early T-dependent B cell responses.
RESULTS

Generation of HEL mutants with varying affi nities for the SW HEL BCR
The role played by initial antigen affi nity in regulating early B cell responses was investigated by generating a panel of recombinant HEL molecules with the capacity to bind over a wide affi nity range to the anti-HEL BCR expressed on SW HEL B cells. SW HEL mice carry a targeted Ig heavy chain variable region gene with a light chain transgene that together encode BCRs with the specifi city of the HyHEL10 mAb (25) . Because the affi nity of WT HEL for HyHEL10 is very high (2 × 10 10 M −1 ) (26), it was necessary to create HEL mutants that bound HyHEL10 with lower affi nities more typical of those found in primary B cell responses. Arginine 21, arginine 73, and aspartate 101 of HEL all form direct contacts with the Ig heavy chain of HyHEL10 (reference 26; Fig.  1 A) and were mutated to glutamine (R21 HEL Q), glutamate (R73 HEL E), and arginine (D101 HEL R) both singly and in combination. Recombinant HEL mutants were expressed in yeast and purifi ed from culture supernatants. All retained lysozyme enzymatic activity and diff ered less than twofold from WT HEL (HEL WT ) in their affi nity for the noncompetitive anti-HEL mAb HyHEL9 (unpublished data), indicating that these point mutations did not aff ect overall protein folding.
As expected, the affi nities of the various HEL mutants for HyHEL10 varied widely. Competitive ELISA studies showed that mutant HEL containing only the D101 HEL R substitution (HEL 1X ) bound with ‫-08ف‬fold lower affi nity than HEL WT to HyHEL10 (Fig. 1 B) , which is in agreement with previous studies (27) . Addition of R73 HEL E to D101 HEL R (HEL 2X ) decreased this affi nity ‫-3ف‬fold, whereas subsequent addition of R21 HEL Q (HEL 3X ) reduced it a further ‫-05ف‬fold. Because HEL 1X and HEL 2X displayed similar affi nities for HyHEL10, only HEL WT , HEL 2X , and HEL 3X were used in subsequent analyses. Based on previous data (18, 26, 27) and our competitive ELISA results, we estimated the affi nities of the recombinant HEL proteins for HyHEL10 to be as follows: 2 × 10 10 M −1 (HEL WT ), 8 × 10 7 M −1 (HEL 2X ), and 1.5 × 10 6 M −1 (HEL 3X ). The relative affi nity measurements of these mutant proteins are also in agreement with the amount of soluble protein needed to stimulate B cells in vitro. Thus, when activation of purifi ed splenic B cells from SW HEL .rag1 −/− (28) mice was analyzed, 10-and 1,000-fold higher concentrations of HEL 2X and HEL 3X , respectively, were required to induce comparable levels of intracellular tyrosine phosphorylation to that triggered by HEL WT (Fig. 1 C) . These recombinant proteins therefore provide the basis for comparing the in vivo responses of SW HEL B cells to high affi nity (HEL WT ), intermediate affi nity (HEL 2X ), and low affi nity (HEL 3X ) antigens.
SW HEL B cells proliferate and form GCs in response to antigens encompassing a 10,000-fold affi nity range To compare T cell-dependent responses to the various HEL proteins, we used a previously described system in which small numbers (10 4 ) of anti-HEL B cells from C57BL/6 (CD45.2 + ) SW HEL donor mice are adoptively transferred into nonirradiated C57BL/6 congenic (CD45.1 + ) recipients and challenged intravenously with HEL conjugated to SRBC (2 × 10 8 ) in the absence of additional adjuvant (6) . HEL is linked to SRBC to recruit SRBC-specifi c T cell help to the SW HEL donor B cells because HEL itself cannot elicit a T cell response ARTICLE on the C57BL/6 genetic background (29) . In this system, the T cell-dependent response of SW HEL donor B cells can be precisely tracked by multiparameter fl ow cytometry based on CD45.2 and HEL-binding BCR expression (6) . As the recipient mice are nonirradiated, responding B cells can navigate normally through intact peripheral lymphoid tissues where their localization can be readily visualized by immunohistology (6) .
We fi rst tested the ability of SW HEL B cells to initiate a primary in vivo response when challenged with SRBC conjugates of the various recombinant HEL proteins. Adoptive transfers were performed using CFSE-labeled donor cells and proliferation of the HEL-binding donor cells was measured 64 h later. Extensive proliferation was observed in response to HEL WT -SRBC, HEL 2X -SRBC, and HEL 3X -SRBC (Fig. 2) . These responses were antigen specifi c because they did not occur upon challenge with mock-conjugated SRBC (Fig. 2) . Although antigen affi nity had some eff ect on the degree of proliferation observed (Fig. 2) , SW HEL B cells nevertheless responded effi ciently to SRBC conjugates of all three recombinant proteins.
We next examined the ability of the SW HEL donor B cells challenged with the various recombinant HEL proteins to diff erentiate into GC B cells. By day 5, immunohistological analysis of spleen sections confi rmed that there was considerable expansion of HEL-binding B cells in response to each of the recombinant HEL proteins, whereas none was evident in mice challenged with mock-conjugated SRBCs (Fig. 3) . Responding HEL-binding B cells were derived from adoptively transferred donor SW HEL B cells because they were not detectable in mice that were challenged with any of the HEL-SRBC conjugates in the absence of cotransferred SW HEL B cells (unpublished data). HEL-binding B cells were found within PNA + GCs from recipients challenged with each of the three HEL-SRBC conjugates (Fig. 3) . By fl ow cytometry, donor-derived GC B cells were identifi ed on the basis of high surface CD45.2 and HEL binding, relatively low intracellular HEL binding, and lack of syndecan-1 (CD138) expression (Fig. 4 ). These cells also expressed high levels of GL7 and Fas (CD95; unpublished data (Fig. 4) . At the peak of the extrafollicular response on day 5, recipients immunized with HEL WT -SRBC and HEL 2X -SRBC contained >100-fold more splenic plasma cells than those challenged with low affi nity HEL 3X -SRBC (Fig. 5 B) . This was refl ected in the relative levels of both total and IgG1 anti-HEL serum antibodies present at this time point ( 
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antigen affi nity exceeded a threshold value substantially higher than that required for GC B cell diff erentiation.
Extrafollicular plasma cell differentiation is also regulated by epitope density
The regulation of extrafollicular plasma cell diff erentiation by initial antigen affi nity is indicative of a pivotal role for the BCR and its interaction with antigen in determining cell fate during early T-dependent B cell responses. Although antigen affi nity alone may be the critical determinant, epitope density can also have a major impact on the strength of the interaction of antigen with the BCR and on subsequent B cell responses (16, 20, 23) . To test whether epitope density as well as affi nity aff ects the decision to undergo early plasma cell versus GC B cell diff erentiation, SW HEL B cells were challenged with SRBCs coupled to varying densities of the diff erent recombinant HEL proteins.
Our initial experiments (Figs. 3-5) indicated an apparent affi nity threshold for early plasma cell diff erentiation located between the affi nities of HEL 2X and HEL 3X for the SW HEL BCR. To test the infl uence of antigen density, we asked whether increasing the density of the low affi nity HEL 3X protein on the SRBC surface might rescue the extrafollicular plasma cell response to this protein and, conversely, whether reducing antigen density might abrogate the extrafollicular response to the intermediate affi nity protein HEL 2X . In addition to the standard SRBC conjugations using 100 μg/ml HEL 2X or HEL 3X , separate conjugations were performed using 1,000 μg/ml HEL 3X and 10 μg/ml HEL 2X . The antigen density on the diff erent SRBC conjugates was compared by fl ow cytometry using the HyHEL9 mAb. The 100-μg/ml HEL 2X and HEL 3X conjugates were found to possess almost identical levels of surface antigen (intermediate density), whereas the density was increased threefold for the 1,000-μg/ml HEL 3X conjugate (high density) and decreased fourfold for the 10-μg/ml HEL 2X conjugate (low density; Fig. 6 A) .
SW HEL B cells were challenged with the various conjugates in adoptive transfer and their responses analyzed on day 5. When equivalent densities of HEL 2X and HEL 3X were used (intermediate densities), affi nity-based regulation of the early plasma cell response was again apparent, with 20-to 30-fold more extrafollicular plasma cells and antibody being generated in response to HEL 2X compared with HEL 3X (Fig. 6 , B and D-F). When the density of HEL 3X on the SRBC was raised threefold (high density), the production of early plasma cells and the secretion of anti-HEL antibody in response to this low affi nity antigen were increased almost 10-fold (Fig. 6, B and D-F) . Conversely, decreasing the density of HEL 2X by fourfold (low density) led to reductions of 5-to 10-fold in the plasma cell and antibody responses to this intermediate affi nity antigen (Fig. 6, B and D-F) . Importantly, the magnitude of the early GC response did not vary greatly when antigen density was either raised or lowered (Fig. 6 , B and C). As a result, the 12-fold diff erence in epitope density between HEL 2X -SRBC (low density) and HEL 3X -SRBC (high density) negated the 50-fold affi nity diff erence between these antigens and resulted in almost identical day 5 responses (Fig. 6, B and C) . Collectively, these fi ndings indicate that it is the strength of the initial antigen-BCR interaction, infl uenced by both epitope density and affi nity, that determines the extent to which responding B cells enter the extrafollicular plasma cell response.
Affi nity-based partitioning of competing B cells between the early plasma cell and GC compartments Although the response of donor SW HEL B cells occurs within the context of an endogenous anti-SRBC antibody response, the monoclonal nature of the SW HEL BCR does not permit the simultaneous analysis of diff erent B cell specifi cities responding to the same antigen. The prediction from our fi nding that the strength of the interaction between antigen and BCR directs cell fate during early T-dependent responses is that B cells expressing alternative BCRs recognizing the same epitope would be diff erentially represented in the extrafollicular plasma cell compartment depending on the strength of their initial interaction with the antigen. Because epitope density would in this case be fi xed, our results predict that the higher affi nity B cells among competing specifi cities will be preferentially represented in extrafollicular foci compared with early GCs.
To test this prediction, we moved out of the monoclonal SW HEL model to take advantage of the fact that mice carrying the targeted heavy chain variable region gene of HyHEL10 without the light chain transgene (gene-targeted mice expressing only the H chain of HyHEL10 without the light chain transgene (SW HEL(H) mice) contain B cells with a range of affi nities for HEL WT due to pairing of the targeted heavy chain with diff erent endogenous κ light chains (24) . In particular, two B cell populations are resolvable by fl ow cytometry using sub-saturating levels of HEL WT , including a population of relatively high affi nity (0.1-0.2% of B cells) and a second population with lower mean affi nity for HEL WT (0.2-0.4% of B cells; reference 24; Fig. 7 A) . Comparisons of BCR binding by the various recombinant HEL proteins indicated that the affi nity for HEL WT of the latter (lower affi nity) SW HEL(H) B cell population was still higher than the affi nity of the SW HEL BCR for HEL 3X (Fig. S2, (Fig. 7 A) . A further control group received only WT C57BL/6 lymph node donor cells and so lacked donor B cells with HEL-binding activity (Fig. 7 A) . On day 5, CD45.2 + , Igκ + donor-derived B cells (including CD45.2 lo , Igκ lo plasma cells) were collectively analyzed by fl ow cytometry (Fig. 7 B) . The cells were stained with a concentration of HEL WT (75 ng/ml) that resolved the high and intermediate affi nity SW HEL(H) responders. Cells were counterstained for surface Ig with anti-κ light chain to identify diff erences in HEL WT -binding caused by diff erential antigen affi nity rather than BCR expression level (Fig. 7 B) . As expected, the anti-HEL WT donor B cells evident in recipients of SW HEL B cells fell almost exclusively within the high-affi nity gate, whereas the only donor B cells detected in recip i ents of WT C57BL/6 lymph node donor cells were resting and did not bind HEL WT (Fig. 7 B) .
Analysis of recipients of SW HEL(H) cells indicated that both high and intermediate affi nity anti-HEL donor B cell populations had been recruited into the response to HEL WT -SRBC (Fig. 7 B) . Importantly, separate analysis of the two responding populations indicated that the proportion of the responding high affi nity SW HEL(H) donor B cells that exhibited a plasma cell phenotype was more than double that observed among the intermediate affi nity responders (i.e., 45 vs. 21%; Fig. 7 C) . Thus, as was predicted from our previous analysis of monoclonal T-dependent responses, the representation of competing B cells in the extrafollicular plasma cell response was greatest for those responders with the highest initial antigen affi nity.
DISCUSSION
Diff erential recognition of antigen by BCRs has long been recognized to play a key role in two specifi c phases of T-dependent B cell responses. The fi rst is when resting B cells are selected to enter the response because this requires the interaction of the BCR with the foreign antigen to exceed a critical threshold. Subsequently, somatically mutated B cells generated within GCs are only propagated if they acquire increased affi nity for the antigen presented in immune complexes on follicular dendritic cells. In between these two Points represent data from individual recipients, whereas the bars show the mean of each group. The results show that, at a fi xed antigen affi nity, early plasma cell and antibody production vary directly according to antigen density, whereas GC responses are relatively unaffected. ARTICLE checkpoints, however, responding B cells must decide whether to enter the GC reaction or undergo rapid plasma cell diff erentiation in extrafollicular proliferative foci. In this study, we demonstrate that this decision is also controlled by the nature of the interaction between the BCR and antigen. Thus, we show that only responding clones that undergo a strong initial interaction with antigen can effi ciently diff erentiate into extrafollicular plasma cells and contribute to the rapid early T-dependent antibody response.
The studies performed here required the production and purifi cation of milligram amounts of the various recombinant HEL proteins. This was achieved using yeast expression and yielded protein preparations that were >95% pure. Nevertheless, the possibility existed that trace amounts of yeastderived products with potential immunomodulatory eff ects could infl uence the results. We consider this to be very unlikely for several reasons. First, the response observed here after challenge with HEL WT -SRBC is indistinguishable from that obtained when native, chicken egg-derived HEL is conjugated to SRBCs (6) . Second, the characteristic responses obtained to each of the HEL mutants was consistent between batches of the same purifi ed protein (unpublished data). Finally, when high and intermediate affi nity B cells competitively responded to the same antigen in the same host, the predicted diff erences in plasma cell production were still observed (Fig. 7) . Together, these observations indicate that our results were not aff ected by the presence of any potential yeast contaminant.
The existence of an antigen-dependent threshold for early plasma cell production was initially evident in this study from the selective absence of the extrafollicular response when SW HEL B cells were challenged with the low affi nity (K a of ‫5.1ف‬ × 10 6 M −1 ) HEL 3X -SRBC antigen (Figs. 1, 3, and 4 ). This result contrasts with the fi ndings from previous studies on T-dependent B cell responses using the chemical hapten NP conjugated to chicken γ-globulin (CGG) carrier protein (NP-CGG). In this system, B cells with a range of initial anti-NP affi nities showed no diff erential localization to extrafollicular foci versus early GCs (11, 30, 31) . Indeed affi nities as low as 10 5 M −1 are represented equally in both extrafollicular foci and early GCs generated after NP-CGG immunization (11) . The results from the anti-NP system have led to the theory that diff erentiation of responding B cells down the two early response pathways is essentially a stochastic process that operates independently of diff erences in antigen recognition (11, 32) . This model predicts that the initial burst of antibody production by extrafollicular plasma cells refl ects the specifi cities of all B cell clones recruited into the response and is therefore predominantly low affi nity. Although this is indeed the case in anti-NP responses (5, 7), analysis of responses to viruses and natural protein epitopes indicates that the initial burst of antibody production to T-dependent antigen is often of relatively high affi nity (>10 7 M −1 ; references [13] [14] [15] .
The disparate requirements for high antigen affi nity in diff erent T-dependent antibody responses can be reconciled by recognizing that it is the strength of the interaction between antigen and BCR that is crucial for regulating this process, rather than antigen affi nity per se. This notion was confi rmed in the present study by showing that SW HEL B cells could produce rapid plasma cell and antibody responses to the low affi nity HEL 3X -SRBC antigen when the density of HEL 3X on the SRBC surface was increased (Fig. 6) . The presence of low affi nity clones in the extrafollicular focus response to NP-CGG is therefore readily explained by the high epitope density on this haptenated protein antigen, which typically carries 16 NP groups per CGG monomer (31). Our results suggest, therefore, that B cells that recognize low affi nity epitopes can still interact suffi ciently strongly with antigen to enter the extrafollicular focus response but only if the epitope is present at relatively high density.
When epitope density is held constant, it is apparent that a 50-fold reduction in antigen affi nity (i.e., HEL 2X -SRBC to HEL 3X -SRBC) can remove the extrafollicular plasma cell response mounted by SW HEL B cells (Figs. 3-5) . Smaller quantitative shifts in the strength of the interaction between the antigen and the BCR by either lowering the density of HEL 2X or increasing the density of HEL 3X on the SRBC surface had signifi cant but less absolute eff ects on the early plasma cell response (Fig. 6) . Similarly, SW HEL(H) B cells that bound HEL WT with intermediate affi nity were capable of eliciting a reduced but still clearly evident plasma cell response on day 5 (Fig. 7) . Collectively, these results demonstrate that there is not a sharp threshold of interaction between antigen and BCR that determines whether or not early plasma cell diff erentiation will occur. Rather, within a certain range of interaction strengths, the relative size of the early plasma cell response is directly related to the strength of that initial antigen interaction.
Whether a strong interaction between BCR and antigen is universally required for extrafollicular focus formation is diffi cult to assess without studying this question directly using other model antigens. The relatively high affi nity of the early antibody response to several T-dependent antigens (13) (14) (15) is certainly consistent with BCR-dependent regulation of extrafollicular plasma cell production also occurring in these cases. Nevertheless, it is possible that adjuvant or other modifying factors alter the quantity or quality of BCR-independent signals delivered to responding B cells by T cells and/or dendritic cells and that these may in turn override the BCRdependent controls described in the current study. It will be interesting to test this possibility in the future by challenging SW HEL B cells with the diff erent mutant HEL proteins in alternative immunogenic forms.
In contrast to T-dependent antigens, T-independent type 2 (TI-2) antigens such as NP-Ficoll typically generate an extrafollicular response only. Abortive GCs can be generated but only if antigen dose and precursor frequency are sufficiently high (33) . This bias of TI-2 responses toward extrafollicular focus formation is also evident in the SW HEL system. Thus, when 10 4 HEL-binding SW HEL B cells are challenged with HEL WT -Ficoll, short-lived extrafollicular plasma cells are generated but not GCs (unpublished data). If the observations of T-dependent responses in the current study can also be applied to TI-2 responses, it is possible to attribute the ability of TI-2 antigens to elicit a strong extrafollicular focus response to the fact that these antigens are typically highly cross-linking (34, 35) and therefore likely to interact strongly with the BCR. In this case, the failure of TI-2 antigens to effi ciently generate GCs most likely refl ects the importance of T cell help in potentiating GC formation. Alternatively, the strength of BCR engagement may eff ect T-dependent and TI-2 responses diff erently, potentially because of modulation in the latter case by co-stimuli delivered through CD21/35 or Toll-like receptor molecules (36) .
The fi nding that quantitative diff erences in antigen recognition regulate cell fate during early T-dependent B cell responses reveals a sophisticated level of control that has presumably evolved to optimize the deployment of responding B cell clones. Linking rapid plasma cell diff erentiation to strong initial interaction with antigen means that the substantial resources required to support plasma cell diff erentiation and subsequent high level antibody production (37) are devoted only to those clones with a good chance of secreting biologically eff ective antibodies (38) . In the case of paucivalent epitopes, this eff ectively means that only relatively high affi nity antibodies are produced (Figs. 2-4) . However, epitopes present at high density may be eff ectively neutralized by antibodies of lower affi nity (39) (40) (41) . Under these specifi c conditions (e.g., high density HEL 3X -SRBC), it makes biological sense for low affi nity B cells to be permitted into the extrafollicular plasma cell response (Fig. 6) . BCR-mediated regulation of early T-dependent responses also ensures that antigen-specifi c specifi cities that make minimal contribution to the initial antibody response are not discarded but specifi cally directed to GCs. Here they can undergo SHM and affi nity maturation and may contribute new eff ective specifi cities at a later stage of the response. This is exemplifi ed when SW HEL B cells are challenged with intermediate density HEL 3X -SRBC, where the absence of an early (day 5) antibody response (Fig. 5 C) is followed by the subsequent accumulation of high affi nity anti-HEL 3X antibodies produced by somatically mutated post-GC plasma cells (unpublished data).
The critical role of a strong antigen-BCR interaction in early plasma cell diff erentiation in vivo is intriguing given that B cells stimulated with T cell-derived signals in vitro undergo effi cient proliferation-linked plasma cell diff erentiation without the need for BCR ligation (32) . This dichotomy suggests that B cell diff erentiation in vivo is infl uenced by additional signals, which, in the absence of strong antigen recognition, suppress the default plasma cell diff erentiation pathway. Because responding B cells can proliferate and enter the GC response without undergoing signifi cant plasma cell ARTICLE diff erentiation (e.g., HEL 3X -SRBC response), it is possible that the GC microenvironment may inhibit this process. If this is true, a strong initial interaction between BCR and antigen may allow at least a proportion of the daughter cells of a responding clone to bypass the GC and undergo plasma cell diff erentiation. The specifi c mechanism involved is not clear but may be based on BCR-mediated alterations in the expression of chemotactic receptors that facilitate extrafollicular migration (1) . Alternatively, more effi cient presentation of antigen-derived peptides facilitated by stronger antigen recognition may result in quantitative or qualitative diff erences in the delivery of T cell help that infl uence the subsequent B cell response. A potential clue may lie in the fact that the progressive lowering of initial antigen affi nity reduced the rate of proliferation of the anti-HEL B cells during the fi rst 64 h of the response (Fig. 2) . It is possible, therefore, that the initial proliferative response may infl uence the ability of responding cells to undergo rapid plasma cell diff erentiation. In this case it is possible that signals delivered independently of the antigen-BCR interaction but with the potential to modify B cell proliferation (e.g., Toll-like receptor ligands) may also impact on the size of the extrafollicular plasma cell response. Studies using the model described here will assist in resolving the specifi c mechanisms involved and further characterize the signals that shape in vivo B cell responses. Such information holds great promise for the future development of novel therapies for autoimmune diseases as well as the optimization of vaccination strategies.
MATERIALS AND METHODS
Recombinant HEL proteins. cDNAs encoding the various mutant HEL proteins were produced by site-directed mutagenesis using engineered PCR primers. Sequences encoding the mature WT and mutant HEL proteins were then cloned directly 3′ of the secretory signal sequence in the yeast expression vector pPIC9K (Invitrogen). A COOH-terminal His(6) tag (SGHHHHHH) was included in each construct. Transformation of yeast (Pichia pastoris) and induction of recombinant HEL expression was performed according to the manufacturer's instructions. Recombinant HEL proteins were purifi ed from yeast culture supernatants by ion-exchange chromatography using HiTrap SP FF columns followed by Ni 2+ affi nity chromatography (both from GE Healthcare). Recombinant HEL proteins were >95% pure as determined by SDS-PAGE and staining with Coomassie blue. Yields ranged from 5-15 mg of purifi ed protein from 600 ml of culture supernatant.
Mice and adoptive transfers. SW HEL (25) , SW HEL .rag1 −/− (28), and SW HEL(H) (24) mice have been described previously. WT C57BL/6 and CD45.1 congenic C57BL/6 mice were obtained from the Animal Resources Centre (Perth, Australia). All mice were maintained on a C57BL/6 background and housed in specifi c pathogen-free environment. All experimental procedures were approved by the University of Sydney Animal Ethics Committee. B cell isolation, CFSE labeling, and conjugation of HEL to SRBC were performed as described previously (6) . SRBC conjugations were performed using recombinant WT or mutant HEL at 100 μg/ml unless otherwise indicated (Fig. 6) . For adoptive transfers, spleen or lymph node cells from SW HEL ELISAs. Anti-HEL antibody levels in sera from immunized mice were analyzed by ELISA as described previously (25) . Competitive ELISA was performed to measure the relative affi nities of the mutant HEL for HyHEL10. For this, plates were fi rst coated with purifi ed HyHEL10, after which 50 ng/ml of biotinylated HEL WT was added in conjunction with varying concentrations of unlabeled recombinant HEL WT , HEL 1X , HEL 2X , and HEL 3X . Non-linear regression based on a one-site competition model was performed using GraphPad Prism software to fi nd the curve-fi t and calculate the halfmaximal inhibitory concentration.
Western blotting. SW HEL .rag1 −/− B cells were isolated and stimulated with varying concentrations of recombinant HEL proteins for 15 min at 37°C, and whole cell lysates were prepared in buff er containing protease and phosphatase inhibitors as described previously (42) . Proteins were separated by SDS-PAGE and membranes probed with mouse antiphosphotyrosine (Upstate Biotechnology) followed by goat anti-mouse IgGhorseradish peroxidase (Santa Cruz Biotechnology, Inc.) and developed with enhanced chemiluminescence (Perbio). Blots were stripped and reprobed with anti-actin antibody (Santa Cruz Biotechnology, Inc.) to control for protein loading.
Immunohistology. Splenic sections were stained for GCs and HEL-binding B cells as previously described (6) .
FACS analysis. Splenocytes were prepared, stained for surface molecules, and analyzed on a FACSCalibur (BD Biosciences) as previously described (6) . Intracellular staining to detect cytoplasmic HEL-binding Ig was performed after fi xation with 10% formalin and permeabilization with 0.2% polyethylene sorbitan monolaurate. GC B cells (low intracellular HEL binding and syndecan-1 expression) and plasma cells (high intracellular HEL binding and syndecan-1 expression) were enumerated using the gates shown in Fig. 4 B. B cells in mice challenged with mock-SRBC fell in the GC B cell gate but were not counted as they had not proliferated (Fig. 2) , did not express GL7 (not depicted), and were shown histologically to be absent from GC (Fig. 3 D) . SHM analysis. Single responding SW HEL B cells were sorted from the spleens of recipient mice 5 d after transfer using a FACSVantage (BD Biosciences). GC and plasma cells were identifi ed using the gates shown in Fig. S1 (available at http://www.jem.org/cgi/content/full/jem.20060087/DC1) and single cells sorted into 96-well plates containing proteinase K (Sigma-Aldrich). The variable region exon of the SW HEL Ig (HyHEL10) heavy chain gene was then PCR amplifi ed using Taq polymerase (Sigma-Aldrich) for 35 
cycles with the primers G T T G T A G C C T A A A A G A T G A T G G T G and G A T A A T C T G T C-C T A A A G G C T C T G A G . The primary PCR product was further amplifi ed for 35 cycles with the nested primers T T G T A G C C T A A A A G A T G A T G G T-G T T A A G T C and C A A C T T C T C T C A G C C G G C T C .
The fi nal PCR product was sequenced with the dideoxy-chain termination method using primer TTGTAGCCTAAAAGATGATGGTGTTAAGTC at the Australian Genomic Research Foundation (Brisbane, Australia). Sequences encoding the mature VDJ region were analyzed for the presence of SHM events.
Online supplemental material. Fig. S1 shows the FACS gating strategy for sorting single cells with the GC and plasma cell phenotypes. 
